Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 214 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Liakopoulos, Vassilios [Clear All Filters]
Increased visfatin in hemodialysis patients is associated with decreased demands for recombinant human erythropoietin..
Ren Fail. 35(10), 1399-403.
(2013). Inhibition of indoleamine 2,3-dioxygenase in mixed lymphocyte reaction affects glucose influx and enzymes involved in aerobic glycolysis and glutaminolysis in alloreactive T-cells..
Hum Immunol. 74(12), 1501-9.
(2013). Inhibition of indoleamine 2,3-dioxygenase not only blocks autoreactive B cell activation, but it also reduces production of antibodies in general: comment on the article by Pigott and Mandik-Nayak..
Arthritis Rheum. 65(7), 1951-2.
(2013). Plasma serotonin and markers of bone formation and bone resorption in hemodialysis patients..
Iran J Kidney Dis. 7(1), 36-41.
(2013). The renal endothelium in diabetic nephropathy..
Ren Fail. 35(4), 592-9.
(2013). Serum osteoprotegerin is markedly increased and may contribute to decreased blood T cell count in hemodialysis patients..
Int Urol Nephrol. 45(6), 1671-7.
(2013). Inverse association of serum 25-hydroxyvitamin D with markers of inflammation and suppression of osteoclastic activity in hemodialysis patients..
Iran J Kidney Dis. 6(2), 129-35.
(2012). Perilipin-1 in hemodialyzed patients: association with history of coronary heart disease and lipid profile..
Ther Apher Dial. 16(4), 355-60.
(2012). Peritoneal dialysis-related infections recommendations: 2010 update. What is new?.
Int Urol Nephrol. 44(2), 593-600.
(2012). Pharmacological management of hypertensive emergencies and urgencies: focus on newer agents..
Expert Opin Investig Drugs. 21(8), 1089-106.
(2012). Plasma indoleamine 2,3-dioxygenase and arginase type I may contribute to decreased blood T-cell count in hemodialysis patients..
Ren Fail. 34(9), 1118-22.
(2012). Plasma indoleamine 2,3-dioxygenase concentration is increased in hemodialysis patients and may contribute to the pathogenesis of coronary heart disease..
Ren Fail. 34(1), 68-72.
(2012). Toll-like receptors and their role in renal pathologies..
Inflamm Allergy Drug Targets. 11(6), 464-77.
(2012). Arginase type I as a marker of coronary heart disease in hemodialysis patients..
Int Urol Nephrol. 43(4), 1187-94.
(2011). Distal renal tubular acidosis (dRTA) and bone histomorphometry..
Kidney Int. 80(4), 431; author reply 431.
(2011). Evidence of increased muscle atrophy and impaired quality of life parameters in patients with uremic restless legs syndrome..
PLoS One. 6(10), e25180.
(2011). Indoleamine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccination..
Vaccine. 29(12), 2242-7.
(2011). Like total ghrelin, acylated ghrelin is also lower in HD patients with cardiovascular disease..
Kidney Int. 80(7), 783; author reply 783-4.
(2011).
(2011).
(2011). Alpha-tocopherol administration decreases serum urate levels in hemodialysis patients..
Ther Apher Dial. 14(6), 605-6.
(2010). No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis: comments from around the world..
Int Urol Nephrol. 42(1), 245-6.
(2010). Non-pharmacological management of periodic limb movements during hemodialysis session in patients with uremic restless legs syndrome..
ASAIO J. 56(6), 538-42.
(2010). Paricalcitol reduces basal and lipopolysaccharide-induced (LPS) TNF-alpha and IL-8 production by human peripheral blood mononuclear cells..
Int Urol Nephrol. 42(1), 181-5.
(2010). Peritoneal dialysis glossary 2009..
Int Urol Nephrol. 42(2), 417-23.
(2010).